These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7796600)

  • 1. The effect of topical retinoic acid (Etretinate) on mouse conjunctival Langerhans cells.
    Kremer I; Gabai U; Arbizo M; Arbizo V; Laibson PR
    Curr Eye Res; 1995 Mar; 14(3):167-72. PubMed ID: 7796600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced density and morphologic alteration of Ia and ADPase positive Langerhans cells after low-protein diet.
    Ghaznawie M; Papadimitriou JM; Heenan PJ
    Br J Dermatol; 1989 Mar; 120(3):341-9. PubMed ID: 2713255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Density of epidermal Langerhans cells in psoriasis patients treated with an aromatic retinoid (RO 10-9359). An immunoperoxidase study using anti-T6 and anti-Ia monoclonal antibodies.
    Guzman de Fleury M; Tapia FJ; Soto J; Ghersi N; Convit J
    Histol Histopathol; 1986 Jul; 1(3):227-34. PubMed ID: 2856536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Langerhans' cells in patients with psoriasis: effect of treatment with PUVA, PUVA bath, etretinate and anthralin.
    Czernielewski J; Juhlin L; Shroot S; Brun P
    Acta Derm Venereol; 1985; 65(2):97-101. PubMed ID: 2408430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of orally administered aromatic retinoid on murine Langerhans cells.
    Shiohara T; Kobayashi M; Narimatsu H; Nagashima M
    Arch Dermatol Res; 1987; 279(3):198-203. PubMed ID: 3296963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Langerhans cells in benign, premalignant and malignant skin lesions of renal transplant recipients and the effect of retinoid therapy.
    Gibson GE; O'Grady A; Kay EW; Leader M; Murphy GM
    J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):130-6. PubMed ID: 9553909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 1alpha,25-dihydroxyvitamin D3 on Langerhans cell migration and corneal neovascularization in mice.
    Suzuki T; Sano Y; Kinoshita S
    Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):154-8. PubMed ID: 10634615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal Langerhans' cells in patients with pustulosis palmoplantaris treated with etretinate or etretinate + methoxsalen photochemotherapy.
    Rosén K; Jontell M; Mobacken H; Rosdahl I
    Acta Derm Venereol; 1988; 68(3):218-23. PubMed ID: 2455414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional assessment of the stratum corneum under the influence of oral aromatic retinoid (etretinate) in guinea-pigs and humans. Comparison with topical retinoic acid treatment.
    Tagami H; Tadaki T; Obata M; Koyama J
    Br J Dermatol; 1992 Nov; 127(5):470-5. PubMed ID: 1467285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of conjunctival transdifferentiation by topical retinoids.
    Tseng SC; Hirst LW; Farazdaghi M; Green WR
    Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):538-42. PubMed ID: 3470270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imiquimod, a topical immune response modifier, induces migration of Langerhans cells.
    Suzuki H; Wang B; Shivji GM; Toto P; Amerio P; Tomai MA; Miller RL; Sauder DN
    J Invest Dermatol; 2000 Jan; 114(1):135-41. PubMed ID: 10620129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of etretinate on epidermal Langerhans cell.
    Mori O; Hachisuka H; Nomura H; Okubo K; Sasai Y
    Kurume Med J; 1988; 35(4):207-9. PubMed ID: 3251113
    [No Abstract]   [Full Text] [Related]  

  • 13. [Reaction of Langerhans cells of the corneal epithelium to topically applied lead].
    Niebrój T; Gruszczyńska M
    Klin Oczna; 1989; 91(2-3):54. PubMed ID: 2593596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative lack of systemic effects of mometasone furoate on Langerhans cells of mice after topical administration as compared with other glucocorticosteroids.
    Belsito DV; Baer RL; Schultz JM; Thorbecke GJ
    J Invest Dermatol; 1988 Sep; 91(3):219-23. PubMed ID: 3166025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration.
    Haftek M; Faure M; Schmitt D; Thivolet J
    J Invest Dermatol; 1983 Jul; 81(1):10-4. PubMed ID: 6345681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Langerhans cells in the cornea and the conjunctiva: its distribution and Ia antigens].
    Tagawa Y; Takeuchi T; Saga T; Matsuda H
    Nippon Ganka Gakkai Zasshi; 1982; 86(8):825-32. PubMed ID: 6960655
    [No Abstract]   [Full Text] [Related]  

  • 17. Pustulosis palmoplantaris and chronic eczematous hand dermatitis. Treatment, epidermal Langerhans cells and association with thyroid disease.
    Rosén K
    Acta Derm Venereol Suppl (Stockh); 1988; 137():1-52. PubMed ID: 3285630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentamidine isethionate reduces Ia expression and antigen presentation by Langerhans cells and inhibits the contact hypersensitivity reaction.
    Blaylock BL; Kouchi Y; Comment CE; Corsini E; Rosenthal GJ; Luster MI
    J Immunol; 1991 Oct; 147(7):2116-21. PubMed ID: 1833452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tumor-promoting agents on density and morphometric parameters of mouse epidermal Langerhans and Thy-1+ cells.
    Baxter CS; Andringa A; Chalfin K; Miller ML
    Carcinogenesis; 1991 Jun; 12(6):1017-21. PubMed ID: 1675159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjunctival inflammation induces Langerhans cell migration into the cornea.
    Suzuki T; Sano Y; Kinoshita S
    Curr Eye Res; 2000 Jul; 21(1):550-3. PubMed ID: 11035535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.